The study, published online Monday in the journal BMJ Quality and Safety, underscores the trade-offs in the diagnostic process: More medical tests generally improve detection, but they can also increase costs, harm patients, and produce false positives.
Novel nanosensors will allow for the rapid detection, diagnosis and prescription of antidotes to deadly biological or chemical agents--such technologies could ensure safety of both armed forces and civilian populations.